169 related articles for article (PubMed ID: 32945400)
1. EphA2‑enriched exosomes promote cell migration and are a potential diagnostic serum marker in pancreatic cancer.
Wei Q; Wei L; Zhang J; Li Z; Feng H; Ren L
Mol Med Rep; 2020 Oct; 22(4):2941-2947. PubMed ID: 32945400
[TBL] [Abstract][Full Text] [Related]
2. Serum Exo-EphA2 as a Potential Diagnostic Biomarker for Pancreatic Cancer.
Wei Q; Zhang J; Li Z; Wei L; Ren L
Pancreas; 2020 Oct; 49(9):1213-1219. PubMed ID: 32898008
[TBL] [Abstract][Full Text] [Related]
3. Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer.
Fan J; Wei Q; Koay EJ; Liu Y; Ning B; Bernard PW; Zhang N; Han H; Katz MH; Zhao Z; Hu Y
Theranostics; 2018; 8(21):5986-5994. PubMed ID: 30613276
[No Abstract] [Full Text] [Related]
4. Upregulated exosomic miR‑23b‑3p plays regulatory roles in the progression of pancreatic cancer.
Chen D; Wu X; Xia M; Wu F; Ding J; Jiao Y; Zhan Q; An F
Oncol Rep; 2017 Oct; 38(4):2182-2188. PubMed ID: 28849236
[TBL] [Abstract][Full Text] [Related]
5. Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer.
Jin H; Liu P; Wu Y; Meng X; Wu M; Han J; Tan X
Cancer Sci; 2018 Sep; 109(9):2946-2956. PubMed ID: 30007115
[TBL] [Abstract][Full Text] [Related]
6. Characterization and proteomic profiling of pancreatic cancer-derived serum exosomes.
Jiao YJ; Jin DD; Jiang F; Liu JX; Qu LS; Ni WK; Liu ZX; Lu CH; Ni RZ; Zhu J; Xiao MB
J Cell Biochem; 2019 Jan; 120(1):988-999. PubMed ID: 30160795
[TBL] [Abstract][Full Text] [Related]
7. Specific detection of soluble EphA2 fragments in blood as a new biomarker for pancreatic cancer.
Koshikawa N; Minegishi T; Kiyokawa H; Seiki M
Cell Death Dis; 2017 Oct; 8(10):e3134. PubMed ID: 29072678
[TBL] [Abstract][Full Text] [Related]
8. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
Wu M; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu Y; Jin H
Life Sci; 2020 Aug; 255():117857. PubMed ID: 32470446
[TBL] [Abstract][Full Text] [Related]
9. Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer.
Sonohara F; Yamada S; Takeda S; Hayashi M; Suenaga M; Sunagawa Y; Tashiro M; Takami H; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Kodera Y
Anticancer Res; 2020 Apr; 40(4):1843-1853. PubMed ID: 32234872
[TBL] [Abstract][Full Text] [Related]
10. Comparative proteomic analysis identifies exosomal Eps8 protein as a potential metastatic biomarker for pancreatic cancer.
Ohshima K; Hatakeyama K; Kanto K; Ide T; Watanabe Y; Moromizato S; Wakabayashi-Nakao K; Sakura N; Yamaguchi K; Mochizuki T
Oncol Rep; 2019 Feb; 41(2):1019-1034. PubMed ID: 30431134
[TBL] [Abstract][Full Text] [Related]
11. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer.
Shang S; Wang J; Chen S; Tian R; Zeng H; Wang L; Xia M; Zhu H; Zuo C
Cancer Med; 2019 Dec; 8(18):7728-7740. PubMed ID: 31642612
[TBL] [Abstract][Full Text] [Related]
13. Murine and human pancreatic tumor exosome recovery in mouse serum: Diagnostic and prognostic potential and target cell delivery.
Erb U; Zhao K; Wang Z; Xiao L; Zöller M
Cancer Lett; 2017 Sep; 403():1-12. PubMed ID: 28619525
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.
Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L
Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of tissue and circulating levels of Ephrin-A2 in prostate cancer.
Li S; Wu Z; Chen Y; Kang Z; Wang H; He P; Zhang X; Hu T; Zhang Q; Cai Y; Xu X; Guan M
Tumour Biol; 2016 Apr; 37(4):5365-74. PubMed ID: 26561474
[TBL] [Abstract][Full Text] [Related]
16. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer.
Wei S; Peng L; Yang J; Sang H; Jin D; Li X; Chen M; Zhang W; Dang Y; Zhang G
J Exp Clin Cancer Res; 2020 Feb; 39(1):32. PubMed ID: 32039741
[TBL] [Abstract][Full Text] [Related]
17. Integrin β4 and vinculin contained in exosomes are potential markers for progression of prostate cancer associated with taxane-resistance.
Kawakami K; Fujita Y; Kato T; Mizutani K; Kameyama K; Tsumoto H; Miura Y; Deguchi T; Ito M
Int J Oncol; 2015 Jul; 47(1):384-90. PubMed ID: 25997717
[TBL] [Abstract][Full Text] [Related]
18. Exosomes in Pancreatic Cancer: from Early Detection to Treatment.
Armstrong EA; Beal EW; Chakedis J; Paredes AZ; Moris D; Pawlik TM; Schmidt CR; Dillhoff ME
J Gastrointest Surg; 2018 Apr; 22(4):737-750. PubMed ID: 29423813
[TBL] [Abstract][Full Text] [Related]
19. Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma.
Qazi MA; Vora P; Venugopal C; Adams J; Singh M; Hu A; Gorelik M; Subapanditha MK; Savage N; Yang J; Chokshi C; London M; Gont A; Bobrowski D; Grinshtein N; Brown KR; Murty NK; Nilvebrant J; Kaplan D; Moffat J; Sidhu S; Singh SK
Cancer Res; 2018 Sep; 78(17):5023-5037. PubMed ID: 29945963
[TBL] [Abstract][Full Text] [Related]
20. c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer.
Lux A; Kahlert C; Grützmann R; Pilarsky C
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
